California-based ZipLine Medical has developed a non-invasive alternative to staples and sutures that is designed to quickly close wounds with the benefit of reducing risk of infection and scarring. The company has announced a more than $16 million round of financing and is looking to raise an additional $10.5 million.
Back in October 2014, ZipLine closed a $5.7 million extension to its Series C financing round. The company’s surgical suture is classified as Class I, 510(k) exempt and has received a CE Mark, as well as regulatory approval in Japan and South Korea. It’s currently available for distribution.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
How the Zip Surgical Skin Closure works is two sticky strips are placed over an incision and then tightened to close it adjustable ratcheted ties – a bandage is then placed on top of the product.
The closure comes in many lengths that can be trimmed to customize and can be used to treat wounds on many parts of the body. Part of the benefit is the flexibility of the product, which makes it easier for patients to continue normal movement without disrupting the healing of the wound.
The company was unavailable to comment on how the financing will be used moving forward before the publication of this article.
Watch an animation of how the ZipLine product works here.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Photo: Screenshot via ZipLine Medical
